Rothschild & Co Hires Jaime Arrastia as Managing Director and Vice Chairman in North America
Senior hire bolsters the firm’s leadership and expertise in the consumer sector NEW YORK–(BUSINESS WIRE)–Rothschild…
Senior hire bolsters the firm’s leadership and expertise in the consumer sector NEW YORK–(BUSINESS WIRE)–Rothschild…
Agreement to deploy a 5 MWe module of Heliogen’s AI-enabled concentrated solar energy technology in…
THE WOODLANDS, Texas–(BUSINESS WIRE)–The Clean Canaveral, a new liquefied natural gas (LNG) bunker barge operating…
Mr. Driscoll has over 25 years of biotech executive experience and most recently served as…
WILMINGTON, Mass.–(BUSINESS WIRE)–Analog Devices, Inc. (NASDAQ: ADI) and Gridspertise, the new subsidiary of the Enel…
Chief Financial Officer Transition Plan Originally Announced on January 11th Ms. Pease Will Join Charles…
Company Secures up to $150 Million in Non-Dilutive Funding from Oxford Finance LLC; Expected Cash…
Q4 revenue up 714% versus prior year to $2.9 million, on increased customer demand for…
HOUSTON–(BUSINESS WIRE)–USD Partners LP (NYSE: USDP) (the “Partnership”) today announced it has entered into an…
Acquisition will add breadth to Sarcos’ family of mobile dexterous robots for use in industrial…
DOD Base Budget Estimated at $665 Billion, a 6% Increase over Fiscal Year 2021 COLUMBIA,…
Company Secures up to $150 Million in Non-Dilutive Funding from Oxford Finance LLC, Providing Additional…
Charles J. Sebaski Joins Ambac as Managing Director, Head of Investor Relations NEW YORK–(BUSINESS WIRE)–Ambac…
LONDON–(BUSINESS WIRE)–KBRA UK (KBRA) is pleased to announce the assignment of preliminary ratings to four…
Focusing on behavioral intelligence, NICE Actimize’s Sales Practices & Suitability solution helps align investment recommendations…
SCOTTSDALE, Arizona, March 28, 2022 – Leading electronic plan review companies Avolve Software and DigEplan…
The Society of Authors, Composers, and Publishers of Music developed a real-time API monitoring system…
Taiho Pharmaceutical Obtains Approval to Manufacture and Market NK1 Receptor Antagonist Arokaris®I.V. Infusion 235mg in…
Expects to add two U.S. Food and Drug Administration (“FDA”)-approved, new chemical entities (“NCEs”) with…
TOKYO, Mar 28, 2022 – (JCN Newswire) – Mitsubishi Heavy Industries EMEA, Ltd. (MHI-EMEA), MHI’s…